# Kindeva Drug Delivery Limited - Inspection Records

Source: https://www.keypedia.com/companies/kindeva-drug-delivery-limited/901e9a7f-5182-43e1-9980-391fca7364b7

> Inspection records and compliance data for Kindeva Drug Delivery Limited in Leicestershire, LE11. Access full analysis and detailed observations.

---

## Details

- Name: Kindeva Drug Delivery Limited
- FEI Number: 3002807586
- City: Leicestershire
- State: LE11
- Country Name: United Kingdom
- Address Line 1: Derby Road
- Address Line 2: Loughborough
- Zip Code: 5SF

## Related Documents

- [FDA Inspection 1298022 - Kindeva Drug Delivery Limited - 2025-03-14](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/6da424cf-6b3c-4349-a8b1-884da0a80150) — source: FDA, date: March 14, 2025
- [FDA Inspection 1298022 - Kindeva Drug Delivery Limited - 2025-03-14](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/a5ace140-0988-48cd-a00b-8a94bbc30da4) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 14, 2025
- [FDA Inspection 1202201 - Kindeva Drug Delivery Limited - 2021-05-27](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/5ba32f0c-a12d-490c-acf6-0f0d17233fe6) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 27, 2021
- [FDA Inspection 1097508 - Kindeva Drug Delivery Limited - 2018-05-03](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/3d5f2dd3-39ff-4723-a463-91e3182a8a20) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 3, 2018
- [FDA Inspection 1061585 - Kindeva Drug Delivery Limited - 2017-06-30](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/6304c010-cac9-455d-a5fc-b4c17dfe9b7e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 30, 2017
- [483 - Kindeva Drug Delivery Limited - 2016-08-12](https://www.keypedia.com/records/483/kindeva-drug-delivery-limited/393c60f6-3623-43c0-ba8c-fefb63f62fff) — source: FDA, date: August 12, 2016
- [FDA Inspection 982337 - Kindeva Drug Delivery Limited - 2016-08-12](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/0ba38acf-fb4c-442a-ba1c-9d1227655764) — classification: Voluntary Action Indicated (VAI), source: FDA, date: August 12, 2016
- [EIR - Kindeva Drug Delivery Limited - 2015-03-05](https://www.keypedia.com/records/eir/kindeva-drug-delivery-limited/ecaaf407-28e9-4049-8ce6-684d77d4132d) — source: FDA, date: March 5, 2015
- [FDA Inspection 922069 - Kindeva Drug Delivery Limited - 2015-03-05](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/a07166af-c0c6-4dd5-a987-c208a2786f38) — classification: No Action Indicated (NAI), source: FDA, date: March 5, 2015
- [483 - Kindeva Drug Delivery Limited - 2013-04-15](https://www.keypedia.com/records/483/kindeva-drug-delivery-limited/e2202e78-a597-488c-8aa0-94c6d3e2da9c) — source: FDA, date: April 15, 2013
- [FDA Inspection 827149 - Kindeva Drug Delivery Limited - 2013-04-15](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/fbbaf9d9-910d-403d-95d1-a58ecdb7de18) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 15, 2013
- [FDA Inspection 581481 - Kindeva Drug Delivery Limited - 2009-04-17](https://www.keypedia.com/records/fda_inspections/kindeva-drug-delivery-limited/8c0c33cd-d664-4cf7-8bcb-092c775eb324) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 17, 2009

## Related Companies

- [Ecolab, Inc.](https://www.keypedia.com/companies/ecolab-inc/b1f974bf-f8ce-4704-bbe7-2b1cc3d35c03)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/02a3eaeb-a765-43ae-873b-93d1d1523696)
- [Western Chemical Inc.](https://www.keypedia.com/companies/western-chemical-inc/f13bfcbc-06d5-4798-b88f-92e71ffad710)
- [Cosco International, Inc.](https://www.keypedia.com/companies/cosco-international-inc/1d902093-955a-4d4e-b6ac-e4deff1773a6)
- [Sandoz GmbH](https://www.keypedia.com/companies/sandoz-gmbh/06a6ffcd-311c-4e6b-8087-573378a1ad87)
- [Galephar Pharmaceutical Research Inc.](https://www.keypedia.com/companies/galephar-pharmaceutical-research-inc/9718f387-543c-4e81-ae61-054ddea9a225)
- [Hikma Pharmaceuticals USA Inc.](https://www.keypedia.com/companies/hikma-pharmaceuticals-usa-inc/646ab738-7dde-4473-abdb-76058836c610)
- [Frontage Laboratories, Inc.](https://www.keypedia.com/companies/frontage-laboratories-inc/1705f97d-14a3-4e46-b8a5-220bf2c4799f)
- [Hospira Australia Pty Ltd.](https://www.keypedia.com/companies/hospira-australia-pty-ltd/43f04346-c63c-4c33-92ed-a42abafdd533)
- [BOEHRINGER INGELHEIM PROMECO S.A. de C.V.](https://www.keypedia.com/companies/boehringer-ingelheim-promeco-sa-de-cv/d1f077c2-d2d3-4a71-b897-7595adbb343b)

## Related Officers

- [Russell J. Glapion](https://www.keypedia.com/people/russell-j-glapion/54dd6274-563a-44fe-8016-2ebd700be7a0)
- [investigator](https://www.keypedia.com/people/michael-l-chasey/37971a80-7af1-4658-9a8d-2d65a2b75ec5)
- [issuing_officer](https://www.keypedia.com/people/jeneen-a-huff-robersone/425ab23a-ab3f-4551-8c8a-fd0014184a99)
- [Development Coordinator](https://www.keypedia.com/people/shawn-e-larson/a3515e47-60a3-48ff-b27c-f79bd03db12b)